Anastrozole

Product Overview

Anastrozole is a nonsteroidal aromatase inhibitor used primarily in the treatment of certain hormone receptor-positive breast cancers in postmenopausal women. It reduces estrogen production by inhibiting the aromatase enzyme, which plays a role in converting androgens into estrogen.

Anastrozole is the active pharmaceutical ingredient in the brand-name medicine Arimidex. It is a prescription medication used under the supervision of qualified healthcare professionals and according to approved clinical indications.

Understanding Anastrozole

Anastrozole belongs to the aromatase inhibitor class of medicines. It works by lowering estrogen levels in the body, which may help reduce estrogen stimulation of certain breast cancer cells.

Unlike selective estrogen receptor modulators, anastrozole does not primarily work by blocking estrogen receptors. Instead, it reduces the production of estrogen through aromatase enzyme inhibition.

Anastrozole is primarily associated with oncology and endocrine therapy. Its use for other purposes should only be considered within an appropriate medical or research framework.

Pharmacological Profile

Active Ingredient

Anastrozole.

Drug Classification

Nonsteroidal aromatase inhibitor.

Therapeutic Area

Oncology and endocrine therapy.

Mechanism of Action

Anastrozole inhibits the aromatase enzyme, which is involved in the conversion of androgens into estrogens.

By reducing aromatase activity, anastrozole lowers estrogen production in postmenopausal women. This can reduce hormonal stimulation of estrogen-sensitive cancer cells.

Pharmacological Effects

The principal pharmacological effect of anastrozole is suppression of estrogen biosynthesis. Its activity is associated with reduced circulating estrogen levels and changes in estrogen-dependent biological processes.

Clinical Applications

1. Hormone Receptor-Positive Breast Cancer

Anastrozole is used in selected cases of hormone receptor-positive breast cancer in postmenopausal women. The treatment approach depends on the patient’s clinical condition, cancer characteristics, and the healthcare professional’s assessment.

2. Adjuvant Endocrine Therapy

Anastrozole may be prescribed as part of adjuvant endocrine therapy following primary treatment for appropriate patients.

3. Advanced or Metastatic Breast Cancer

It may be used in selected cases of advanced or metastatic hormone-sensitive breast cancer in accordance with approved indications and specialist guidance.

4. Pharmaceutical and Clinical Research

Anastrozole may be studied in research involving:

• Aromatase enzyme inhibition
• Estrogen biosynthesis
• Endocrine signaling
• Hormone-dependent cancers
• Endocrine therapy response
• Pharmacokinetics and drug metabolism
• Hormonal treatment safety

Key Product Features

1. Active Pharmaceutical Ingredient

Anastrozole.

2. Drug Class

Aromatase inhibitor.

3. Brand Association

Arimidex is a well-known brand associated with anastrozole.

4. Therapeutic Application

Primarily used in selected hormone-sensitive breast cancer treatment protocols.

5. Pharmaceutical Form

Anastrozole is commonly supplied as oral tablets, although the exact formulation and strength depend on the manufacturer and approved product.

6. Prescription Status

Anastrozole is a prescription medicine. Its supply, prescribing, and distribution are subject to applicable laws and regulatory requirements.

Safety Considerations

Anastrozole can cause adverse effects associated with estrogen reduction and its pharmacological activity.

Potential adverse effects include:

• Hot flashes
• Joint pain or stiffness
• Muscle discomfort
• Fatigue
• Headache
• Nausea
• Mood changes
• Reduced bone mineral density
• Increased risk of osteoporosis
• Changes in blood lipid levels

The occurrence and severity of adverse effects vary between individuals. Medical supervision and appropriate monitoring are important during treatment.

Bone Health

Long-term estrogen suppression may contribute to reduced bone mineral density in some patients. Healthcare professionals may evaluate bone health and determine whether monitoring or supportive treatment is appropriate.

Cardiovascular and Metabolic Considerations

Changes in lipid levels and other cardiovascular risk factors may occur. Individual risk assessment should be conducted by the treating healthcare professional.

Drug Interactions

Patients should disclose all prescription medicines, over-the-counter products, supplements, and hormonal therapies to their healthcare professional. Potential interactions should be assessed using approved prescribing information.

Precautions

The official product documentation should be reviewed before treatment. Important considerations may include:

• Pregnancy
• Breastfeeding
• Premenopausal status
• Osteoporosis or fracture risk
• Liver disease
• Kidney-related medical conditions
• Cardiovascular risk factors
• Concurrent hormonal treatments

Anastrozole is generally intended for use in postmenopausal patients for approved clinical indications. Its use should be determined by a qualified healthcare professional.

Product Information

Storage and Handling

Storage requirements depend on the specific formulation, packaging, and manufacturer.

General handling recommendations include:

• Store according to the official product label.
• Keep the medicine in its original packaging where possible.
• Protect the product from unsuitable temperatures and moisture as specified.
• Keep it out of reach of children.
• Do not use expired or damaged products.
• Follow applicable pharmaceutical disposal requirements.

Frequently Asked Questions

What is Anastrozole?

Anastrozole is a nonsteroidal aromatase inhibitor used primarily in the treatment of selected hormone receptor-positive breast cancers in postmenopausal women.

What is the difference between Anastrozole and Arimidex?

Anastrozole is the active pharmaceutical ingredient, while Arimidex is a brand name associated with anastrozole.

How does Anastrozole work?

Anastrozole inhibits the aromatase enzyme, reducing estrogen production in postmenopausal women. This can reduce estrogen stimulation of certain hormone-sensitive cancer cells.

Is Anastrozole a steroid?

No. Anastrozole is classified as a nonsteroidal aromatase inhibitor.

Is Anastrozole a prescription medicine?

Yes. Anastrozole is a prescription medication and should be used under qualified medical supervision.

What are common side effects?

Possible side effects include hot flashes, joint discomfort, muscle pain, fatigue, headache, and other symptoms associated with reduced estrogen levels.

Can Anastrozole affect bone health?

Yes. Estrogen reduction may contribute to bone mineral loss and increased fracture risk in some patients. Bone health should be assessed based on individual clinical risk.

What documentation should be reviewed?

Relevant documentation may include the official product label, prescribing information, formulation details, safety information, and applicable regulatory records.

Important Safety Disclaimer

This information is provided for general pharmaceutical and educational purposes. Anastrozole is a prescription oncology medicine and should be used only under the direction of a qualified healthcare professional.

This content does not replace medical advice, official prescribing information, or regulatory documentation. Do not begin, change, or discontinue hormonal or cancer treatment without consulting an authorized healthcare professional.